1. Home
  2. VKTX vs KMPR Comparison

VKTX vs KMPR Comparison

Compare VKTX & KMPR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • VKTX
  • KMPR
  • Stock Information
  • Founded
  • VKTX 2012
  • KMPR 1990
  • Country
  • VKTX United States
  • KMPR United States
  • Employees
  • VKTX N/A
  • KMPR N/A
  • Industry
  • VKTX Biotechnology: Pharmaceutical Preparations
  • KMPR Property-Casualty Insurers
  • Sector
  • VKTX Health Care
  • KMPR Finance
  • Exchange
  • VKTX Nasdaq
  • KMPR Nasdaq
  • Market Cap
  • VKTX 3.5B
  • KMPR 4.2B
  • IPO Year
  • VKTX 2015
  • KMPR N/A
  • Fundamental
  • Price
  • VKTX $34.42
  • KMPR $60.39
  • Analyst Decision
  • VKTX Strong Buy
  • KMPR Strong Buy
  • Analyst Count
  • VKTX 13
  • KMPR 4
  • Target Price
  • VKTX $86.92
  • KMPR $78.25
  • AVG Volume (30 Days)
  • VKTX 4.1M
  • KMPR 640.6K
  • Earning Date
  • VKTX 07-23-2025
  • KMPR 08-05-2025
  • Dividend Yield
  • VKTX N/A
  • KMPR 2.12%
  • EPS Growth
  • VKTX N/A
  • KMPR N/A
  • EPS
  • VKTX N/A
  • KMPR 5.35
  • Revenue
  • VKTX N/A
  • KMPR $4,689,100,000.00
  • Revenue This Year
  • VKTX N/A
  • KMPR $3.29
  • Revenue Next Year
  • VKTX N/A
  • KMPR $12.29
  • P/E Ratio
  • VKTX N/A
  • KMPR $11.29
  • Revenue Growth
  • VKTX N/A
  • KMPR N/A
  • 52 Week Low
  • VKTX $18.92
  • KMPR $53.57
  • 52 Week High
  • VKTX $81.73
  • KMPR $73.01
  • Technical
  • Relative Strength Index (RSI)
  • VKTX 73.08
  • KMPR 40.90
  • Support Level
  • VKTX $31.22
  • KMPR $61.14
  • Resistance Level
  • VKTX $33.61
  • KMPR $62.47
  • Average True Range (ATR)
  • VKTX 1.77
  • KMPR 1.14
  • MACD
  • VKTX 0.32
  • KMPR -0.12
  • Stochastic Oscillator
  • VKTX 89.49
  • KMPR 5.80

About VKTX Viking Therapeutics Inc.

Viking Therapeutics Inc is a healthcare service provider. The company specializes in the area of biopharmaceutical development focused on metabolic and endocrine disorders. The company's clinical program pipeline consists of VK2809, VK5211, VK0214 products. VK2809 and VK0214 are orally available, tissue and receptor-subtype selective agonists of the thyroid hormone receptor beta. VK5211 is an orally available, non-steroidal selective androgen receptor modulator.

About KMPR Kemper Corporation

Kemper Corp is a diversified insurance company that provides services in property and casualty insurance, along with life and health insurance. The company's property and casualty segment offers personal and commercial lines for home and automotive products. The company conducts its operations through two operating segments: Specialty Property & Casualty Insurance, and Life Insurance.

Share on Social Networks: